Table 1 Patient characteristics human AAA cohorts
Controls SMART (n = 190) | AAA SMART (n = 187) | AAA Vienna (n = 28) | Controls Stockholm (n = 35) | AAA Stockholm (n = 68) | |
|---|---|---|---|---|---|
Aortic diameter | |||||
Median (SD) | 16 (1.2) | 54 (10.0) | 49 (8.1) | 18 (1.9) | 40 (4.1) |
Range | 13–17 | 42–110 | 31–68 | 15–23 | 35–49 |
Age in years | |||||
Median (SD) | 69 (7.9) | 69 (6.8) | 74 (8.6) | 65 (0.0) | 65 (0.0) |
Range | 44–80 | 48–80 | 58–89 | 65–65 | 65–65 |
Sex | |||||
Male (%) | 178 (94) | 177 (95) | 25 (89) | 35 (100) | 68 (100) |
Female (%) | 12 (6) | 10 (5) | 3 (11) | 0 (0) | 0 (0) |
BMI | |||||
Median (SD) | 26.2 (3.58) | 26.2 (3.41) | 27.0 (4.13) | 25.7 (3.16) | 28.1 (4.40) |
Range | 18.8–42.6 | 19.0–38.8 | 19.3–37.6 | 21.1–34.6 | 19.2–41.7 |
Smoking | |||||
Current (%) | 34 (18) | 77 (41)**** | 9 (32) | 2 (6) | 23 (34)** |
Ever (%) | 143 (75) | 176 (91)**** | 25 (89) | 16 (46) | 63 (93)**** |
Risk factors | |||||
Hypertension (%) | 108 (57) | 109 (58) | 25 (89) | 24 (69) | 40 (59) |
Hyperlipidaemia (%) | 167 (89) | 174 (93) | 21 (75) | 5 (14) | 31 (46)** |
CHD (%) | 84 (44) | 83 (44) | 9 (32) | 1 (3) | 19 (28)** |
DM2 (%) | 50 (26) | 16 (9)**** | 8 (29) | 2 (6) | 20 (29)** |
